Rashes, skin reactions not dangerous
Getting COVID-19 can cause all manner of odd skin reactions. A new study finds some of them, including COVID toes, a measleslike rash and shingles also can be rare, and thankfully brief, side effects of getting the Pfizer-BioNTech or Moderna vaccines.
The minor, though sometimes itchy and annoying, reactions were seen in a database of 414 cases of delayed skin problems linked to the vaccines and reported to health care professionals. The cases were collected between December and February, before the Johnson & Johnson vaccine had been authorized, so it was not included.
None caused a life-threatening reaction, a finding the study’s senior author Dr. Esther Freeman found reassuring.
“People can get full-body rashes, and that can be surprising and a little scary, but these patients did extremely well, recovered and were able to go back and get their second dose,” said Freeman, director of global health dermatology at Massachusetts General Hospital.
Joe Biden has vowed vaccine eligibility for all adults by April 19:But what about appointment availability?
“For people whose rashes started four or more hours after getting the vaccine, zero percent of them went on to get anaphylaxis or any other serious reaction,” she said. “Zero is a nice number.”
The delayed skin responses described in the study often start a day or so after vaccination, but can appear as long as seven to eight days later. They are different from severe and immediate allergic reactions, which occur within the first four hours of getting vaccinated.
The findings appeared Wednesday in the Journal of the American Academy of Dermatology. Becausethe cases include only those reported to a dermatological registry, it’s impossible to say how common they across all people getting the vaccines. In general, the researchers believe them to be rare given the low numbers seen among patients.
While skin reactions to the vaccines can occur, as long as they start more than four hours after vaccination, they are generally not life-threatening.
“People can feel reassured about getting the second dose of their vaccine,” said Freeman, who is the principal investigator for the international COVID-19 Dermatology Registry. “Even if you have a pretty impressive rash after the vaccine, as long as it didn’t start within four hours of vaccination you should feel comfortable getting the second dose.”
Researchers point out that most people who get vaccinated do so without developing any reaction. The Moderna and Pfizer-BioNTech clinical trials reported rare skin reactions, and a recent study of almost 65,000 people found that anaphylaxis after vaccination was an unusual event.
Anyone experiencing severe symptoms should consult a health care professional, Freeman said.
Having a skin response to the first dose of a vaccine doesn’t mean you will have one to the second dose. Fewer than half – 43% – of patients who got a rash in response to their first dose of vaccine had a rash after their second.
The most commonly reported reaction was a raised, sometimes itchy red rash, often at the site of the injection, which can occur up to a week or so after being vaccinated. It’s been called COVID arm or Moderna arm, as about 95% of the reactions occur with the Moderna vaccine.
For Moderna arm, most people had no reoccurrence when they got their second shot. Among those who did, it was generally less pronounced, and faded on average within three to four days.
COVID toes were another rare, annoying but not life-threatening reaction. Also called pernio or chilblains, the skin sores or bumps occur on a patient’s toes, and in about 10% of cases on the fingers. They can cause red or purple swelling of the digits and are likely linked to inflammation of the blood vessel walls.
“Having your toes turn purple is uncomfortable but it’s not a reason to not get the second dose,” Freeman said.
An all-body rash reported by some patients, called a morbilliform rash, often is referred to as “measleslike” though it isn’t measles.
There were a few reports of people who had had chickenpox as children having a shingles outbreak in response to the vaccine.
Another reaction was skin swelling in people who have had dermatologic fillers as a cosmetic treatment, though it was very rare.
“If you’ve had facial filler, it doesn’t mean you shouldn’t get the vaccine,” Freeman said.
Among those who had an immediate allergic reaction to the Pfizer-BioNTech or Moderna vaccines, it was rare, and no deaths have been reported.
A study of 65,000 employees at Massachusetts General Hospital who were vaccinated with either the Pfizer or Moderna vaccine found the rate of life-threatening anaphylaxis was 0.025%.
“That’s one-fortieth of 1%,” Freeman said. “That’s a really nice low number.”
Contact Elizabeth Weise at email@example.com